EBS CIK: 1367644

Emergent BioSolutions Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
320
FY22:
−34.1
FY23:
−206
FY24:
58.7
FY25:
171
Change from FY21 to FY25
millions USD
FY21:
−224
FY22:
−381
FY23:
212
FY24:
125
FY25:
69.4
Change from FY21 to FY25
millions USD
FY21:
−141
FY22:
481
FY23:
−536
FY24:
−190
FY25:
−137
millions USD
FY21:
−45.2
FY22:
66.3
FY23:
−531
FY24:
−6.10
FY25:
104
(positive)
Change from FY21 to FY25
millions USD
FY21:
96.1
FY22:
−150
FY23:
−258
FY24:
35.8
FY25:
157

All amounts in millions USD Data source:SEC EDGAR